Drug Type Small molecule drug |
Synonyms Amlodipine Besilate/Atorvastatin Calcium Hydrate, Amlodipine Besylate/Atorvastatin Calcium Hydrate, Amlodipine/atorvastatin + [6] |
Target |
Action inhibitors, blockers |
Mechanism HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), VDCCs blockers(Voltage-gated calcium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (30 Jan 2004), |
Regulation- |
Molecular FormulaC26H31ClN2O8S |
InChIKeyZPBWCRDSRKPIDG-UHFFFAOYSA-N |
CAS Registry111470-99-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Amlodipine Besylate/Atorvastatin Calcium | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hyperlipoproteinemia Type II | Japan | 07 Jul 2009 | |
Angina Pectoris | China | 03 Apr 2008 | |
Coronary Disease | China | 03 Apr 2008 | |
Hyperlipidemias | China | 03 Apr 2008 | |
Hypercholesterolemia | China | 19 Apr 2005 | |
Angina Pectoris, Variant | United States | 30 Jan 2004 | |
Angina, Stable | United States | 30 Jan 2004 | |
Dyslipidemias | United States | 30 Jan 2004 | |
Heterozygous familial hypercholesterolemia | United States | 30 Jan 2004 | |
Homozygous familial hypercholesterolemia | United States | 30 Jan 2004 | |
Hyperlipoproteinemia Type III | United States | 30 Jan 2004 | |
Hypertension | United States | 30 Jan 2004 | |
Hypertriglyceridemia | United States | 30 Jan 2004 | |
Primary hypercholesterolemia | United States | 30 Jan 2004 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypertension | Discovery | Hong Kong | 01 May 2004 | |
Hypertension | Discovery | Jordan | 01 May 2004 | |
Hypertension | Discovery | Australia | 01 May 2004 | |
Hypertension | Discovery | Turkey | 01 May 2004 | |
Hypertension | Discovery | Mexico | 01 May 2004 | |
Hypertension | Discovery | Saudi Arabia | 01 May 2004 | |
Hypertension | Discovery | Tunisia | 01 May 2004 | |
Hypertension | Discovery | United Arab Emirates | 01 May 2004 | |
Hypertension | Discovery | India | 01 May 2004 | |
Hypertension | Discovery | Israel | 01 May 2004 |
Not Applicable | - | Amlodipine/Atorvastatin 2.5/5 mg | (iequmqzhhl) = eunbtoauru fzimkaqvkx (lihtbsesrc ) View more | Positive | 11 Nov 2014 | ||
Amlodipine/Atorvastatin 2.5/10 mg | (iequmqzhhl) = nprkdnihdj fzimkaqvkx (lihtbsesrc ) View more | ||||||
Phase 4 | 159 | (eikdkmburp) = cnidemlgbr eqnmvuxakm (brofovsmbz, qlwtvhauuu - ntetkizpeo) View more | - | 03 Dec 2012 | |||
Phase 4 | 1,531 | wctqebvhmh(tksvmoczpw) = mpvfmjlcfn tjmukvadbm (bmugxvmhsl, xfhotcgrch - sqizdwobvc) View more | - | 11 Nov 2011 | |||
Phase 4 | 245 | placebo+Caduet (Norvasc + TLC) | aqexvrezsr(vmdaqzlzpk) = fsybgumdbp uutugazuhg (fotjpacedq, jlerefrqxm - dgnyjkstch) View more | - | 06 Nov 2009 | ||
Norvasc placebo+atorvastatin calcium+TLC+amlodipine besylate (Caduet + TLC) | aqexvrezsr(vmdaqzlzpk) = yurngrmqqg uutugazuhg (fotjpacedq, jrchrthraa - xbyuujznlv) View more | ||||||
Phase 3 | 165 | (CI-1038 2.5 mg/5 mg) | wsixmqtnkm(uqcdcgyujw) = gqhyrrzzdu sdqgeaqkoy (pcgregtxri, rjnlrbqesb - dsfsswacrw) View more | - | 13 Apr 2009 | ||
(CI-1038 2.5 mg/10 mg) | wsixmqtnkm(uqcdcgyujw) = iuarrwlfrv sdqgeaqkoy (pcgregtxri, reeuygftxp - jqdcfxovcp) View more |